Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.
about
Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services.Relationship between Low-Income Patient Census and Substance Use Disorder Treatment Programs' Availability of Tobacco Cessation Services.Sustained, new, never, and discontinued tobacco cessation services adopters.Determining the predictors of innovation implementation in healthcare: a quantitative analysis of implementation effectiveness.Factors Linked to Substance Use Disorder Counselors' (Non)Implementation Likelihood of Tobacco Cessation 5 A's, Counseling, and Pharmacotherapy.Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs.Substance Use Disorder Counselors' Reports of Tobacco Cessation Services Availability, Implementation, and Tobacco-related Knowledge.Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.Implementation of smoking cessation treatment in substance use disorder treatment settings: a review.Cigarette Smoking Is Associated With Increased Risk of Substance Use Disorder Relapse: A Nationally Representative, Prospective Longitudinal Investigation.Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.A qualitative evaluation of mental health clinic staff perceptions of barriers and facilitators to treating tobacco use.Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling.Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders
P2860
Q30202808-0FD2DC22-5D81-4CF7-89D8-B15C71030490Q34703291-C91C5B81-665B-4066-BC2C-509AF8CC4C41Q34778801-DFD3C1F2-9BC3-4003-AFE0-DCB914012C32Q35016041-41AA4896-EF9C-477F-B485-FCDFEF841344Q35621191-EF6E0945-341A-4009-A379-6C6BB9636FEAQ35952356-231B96D1-C652-4BF1-9DFC-B736D176ACB2Q35992921-28F9E105-B0D8-4080-AB69-74AF02011B2DQ36240322-D7A60F6B-BE60-4FB8-B9B7-6EB70A9852F2Q38868326-92ED397F-021F-41F3-AEFF-BA25253F8447Q40320181-3858D821-9E4C-4136-B015-7D96B1C81D16Q46067827-528F2B30-C34C-4CD5-B17B-045E0595AAE5Q47270728-56325A14-8165-4C82-A79E-F705B60A90DFQ47591501-75FD3396-8227-4868-95EC-BFE5FB58835DQ52307294-325A9085-F801-43C5-864D-9DD99E5A5524Q58131549-A0BB4CF5-C50D-4EED-B971-EEAEFA5914B7
P2860
Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Organizational factors as pred ...... addiction treatment programs.
@en
Organizational factors as pred ...... addiction treatment programs.
@nl
type
label
Organizational factors as pred ...... addiction treatment programs.
@en
Organizational factors as pred ...... addiction treatment programs.
@nl
prefLabel
Organizational factors as pred ...... addiction treatment programs.
@en
Organizational factors as pred ...... addiction treatment programs.
@nl
P2860
P1476
Organizational factors as pred ...... n addiction treatment programs
@en
P2093
Jessica L Muilenburg
Lillian T Eby
P2860
P356
10.1097/ADM.0000000000000008
P577
2014-01-01T00:00:00Z